Targeting <scp>PPP1R14B</scp> overcomes immunotherapy resistance in prostate cancer by restoring <scp>CD8</scp> <sup>+</sup> T‐cell infiltration via the Nrf2/ <scp>CX3CL1</scp> axis

Jie Yang, Chuan Zhou, Wenbo Zhang, Han He, Jia Wang, Chao Wang, Fenghai Zhou

Open source

DOI: 10.1002/path.70133
Published: 2026-09-22
Container: The Journal of Pathology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/path.70133,
  title = {Targeting
                    <scp>PPP1R14B</scp>
                    overcomes immunotherapy resistance in prostate cancer by restoring
                    <scp>CD8</scp>
                    <sup>+</sup>
                    T‐cell infiltration via the Nrf2/
                    <scp>CX3CL1</scp>
                    axis},
  author = {Jie Yang and Chuan Zhou and Wenbo Zhang and Han He and Jia Wang and Chao Wang and Fenghai Zhou},
  year = {2026},
  journal = {The Journal of Pathology},
  doi = {10.1002/path.70133},
  url = {https://doi.org/10.1002/path.70133}
}

RIS

TY  - JOUR
TI  - Targeting
                    <scp>PPP1R14B</scp>
                    overcomes immunotherapy resistance in prostate cancer by restoring
                    <scp>CD8</scp>
                    <sup>+</sup>
                    T‐cell infiltration via the Nrf2/
                    <scp>CX3CL1</scp>
                    axis
AU  - Jie Yang
AU  - Chuan Zhou
AU  - Wenbo Zhang
AU  - Han He
AU  - Jia Wang
AU  - Chao Wang
AU  - Fenghai Zhou
PY  - 2026
JO  - The Journal of Pathology
DO  - 10.1002/path.70133
UR  - https://doi.org/10.1002/path.70133
ER  -

APA

Yang, J., Zhou, C., Zhang, W., He, H., Wang, J., Wang, C., & Zhou, F. (2026). Targeting <scp>PPP1R14B</scp> overcomes immunotherapy resistance in prostate cancer by restoring <scp>CD8</scp> <sup>+</sup> T‐cell infiltration via the Nrf2/ <scp>CX3CL1</scp> axis. The Journal of Pathology. https://doi.org/10.1002/path.70133

Source records

crossref · retrieved 2026-09-25T04:40:41.476Z